IXICO (LON:IXI) Share Price Crosses Below 200-Day Moving Average – What’s Next?

IXICO plc (LON:IXI – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 8.28 and traded as low as GBX 7.50. IXICO shares last traded at GBX 7.50, with a volume of 10,000 shares trading hands.

IXICO Price Performance

The company’s 50-day moving average is GBX 8.37 and its 200-day moving average is GBX 8.28. The firm has a market capitalization of £16.42 million, a price-to-earnings ratio of -3.85, a PEG ratio of -0.38 and a beta of 0.13. The company has a debt-to-equity ratio of 5.22, a current ratio of 2.83 and a quick ratio of 4.90.

Get IXICO alerts:

IXICO (LON:IXI – Get Free Report) last issued its earnings results on Tuesday, May 19th. The company reported GBX (1.21) earnings per share for the quarter. The firm had revenue of GBX 395 million during the quarter. IXICO had a negative return on equity of 16.18% and a negative net margin of 24.98%. On average, research analysts expect that IXICO plc will post -289.3584879 earnings per share for the current year.

Insider Activity

In other IXICO news, insider Mark Warne bought 50,006 shares of the business’s stock in a transaction dated Wednesday, July 15th. The shares were acquired at an average price of GBX 8 per share, with a total value of £4,000.48. 3.07% of the stock is owned by insiders.

IXICO Company Profile

(Get Free Report)

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.

Featured Articles

• Five stocks we like better than IXICO
• Datadog’s Drop Says More About Expectations Than Earnings
• D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
• Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
• Solventum Nears Inflection Point As It Begins to Unlock Value

Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.